Sotera Health to Acquire BioScience Laboratories to Expand its Antimicrobial and Antiviral Testing Capabilities

Published on: 
In the Lab eNewsletter, Pharmaceutical Technology's In the Lab eNewsletter 04-07-2021, Volume 16, Issue 4

The acquisition will expand the antimicrobial and antiviral testing capabilities of Sotera’s Nelson Labs business in the US.

Sotera Health, a US-based provider of sterilization, lab-testing, and advisory services, announced on March 10, 2021 that it has acquired BioScience Laboratories, a topical antimicrobial product testing company located in the US.

The acquisition will expand the antimicrobial and antiviral testing capabilities of Sotera’s Nelson Labs business in the US, Sotera said in a company press release. Financial details of the acquisition were not disclosed.

“BioScience Laboratories is premier provider of antimicrobial testing services; known for its testing of consumer hand sanitizers, pre-operating hand-wash, and hard surface disinfectants. It is also recognized for its strong relationships with its customers and regulators,” said Michael B. Petras Jr., chairman and CEO of Sotera Health, in the press release. “This acquisition will expand and further strengthen our antimicrobial and virology lab testing capabilities. We welcome BioScience Laboratories’ strong management and expert staff as they join us in our mission, safeguarding global health.”

Advertisement

Source: Sotera